Inventor
YANG PAN-CHYR
TW31 patents
⚠️ This page may combine multiple inventors who share the name “YANG PAN-CHYR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACADEMIA SINICA
12 patentsUS6218114B1Apr 17, 2001
Methods for detecting differentially expressed genes
ACADEMIA SINICA59 citations93
US5789173AAug 4, 1998
Methods for rapid antimicrobial susceptibility testing
ACADEMIA SINICA52 citations89
US11919886B2Mar 5, 2024
4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
ACADEMIA SINICA0 citations58
US11434229B2Sep 6, 2022
4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
ACADEMIA SINICA0 citations58
US12109207B2Oct 8, 2024
Methods of using 4(1H)-quinolone derivatives
ACADEMIA SINICA0 citations55
US11638705B2May 2, 2023
4(1H)-quinolone derivatives and uses thereof
ACADEMIA SINICA0 citations55
US11447778B2Sep 20, 2022
TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases
ACADEMIA SINICA0 citations53
US9891227B2Feb 13, 2018
Ultrasensitive detection of a biological target by aptamer-conjugated gold nanoparticles
ACADEMIA SINICA1 citations51
US10329570B2Jun 25, 2019
Antagonistic PD-1 aptamer and its applications in cancer therapy related applications
ACADEMIA SINICA0 citations48
US10584341B2Mar 10, 2020
Antagonistic PDL1 aptamers and their applications in cancer therapy
ACADEMIA SINICA0 citations46
US10765681B2Sep 8, 2020
Purine compounds possessing anticancer activity
ACADEMIA SINICA0 citations39
US10533179B2Jan 14, 2020
Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity
ACADEMIA SINICA0 citations35
UNIV NAT TAIWAN
8 patentsUS7745134B2Jun 29, 2010
Predicting post-treatment survival in cancer patients with microRNAs
UNIV NAT TAIWAN2 citations59
US7354709B2Apr 8, 2008
Collapsin response mediator protein-1
UNIV NAT TAIWAN6 citations58
US11834682B2Dec 5, 2023
Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
UNIV NAT TAIWAN0 citations56
US7601693B2Oct 13, 2009
Composition for treating cancer and use thereof
UNIV NAT TAIWAN1 citations56
US12013513B2Jun 18, 2024
Metasurface based device for generating abrupt autofocusing beam
UNIV NAT TAIWAN0 citations52
US12085570B2Sep 10, 2024
Biomarkers for lung cancer stem cells
UNIV NAT TAIWAN0 citations46
US10865388B2Dec 15, 2020
Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
UNIV NAT TAIWAN0 citations46
US10155993B2Dec 18, 2018
Method or kit for determining lung cancer development
UNIV NAT TAIWAN1 citations46
ADVPHARMA INC
3 patentsUS7211660B2May 1, 2007
Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences
ADVPHARMA INC2 citations55
US7955800B2Jun 7, 2011
Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
ADVPHARMA INC1 citations45
US7655779B2Feb 2, 2010
Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences
ADVPHARMA INC0 citations45